IGC Pharma, Inc. (NYSE American:IGC) announced that Alliance Global Partners (AGP) has published an updated equity research report. The report reiterates a Buy rating for IGC Pharma and sets a price target of $3.00 per share. IGC Pharma emphasizes that the report’s views are solely those of the analysts and not endorsed by the company.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
IGC Pharma Announces Equity Research Update by Alliance Global Partners
IGC Pharma, Inc. (NYSE American:IGC) announced that Alliance Global Partners (AGP) has published an updated equity research report. The report reiterates a Buy rating for IGC Pharma and sets a price target of $3.00 per share. IGC Pharma emphasizes that the report’s views are solely those of the analysts and not endorsed by the company.